NRx Pharmaceuticals, Inc.

NRXPNASDAQHealthcare● Active

$4.34

+$0.01(+0.23%)

Market Cap$75019999

P/E Ratio—

52W High$5.055

52W Low$1.62

Avg Volume1.2M

Open$4.36

Beta2.19

Overview

NRx Pharmaceuticals, Inc. (NRXP) Number of Employees – History & Annual Headcount

Annual SEC headcount, year-over-year change, and per-employee efficiency — chart and full history below.

SEC EDGAR · FMP · NRXP · as of Mar 23, 2026

Latest filing snapshot

200,000

+0+0.00%vs prior year

NRx Pharmaceuticals, Inc. (NRXP) employee data is sourced from the annual SEC 10-K filing. As of 2025, full-time employees only. Global consolidated headcount. View SEC filing ↗

SEC 10-K·Period end: 2025-12-31·Full-time · Global

Total Employees

200,000

Change (1Y)

Growth % (1Y)

+0.00%

Revenue / Employee

Net Income / Employee

$-143

Market Cap

$75M

NRXP Employee Count

2017 – 2025 · Annual · SEC filing

Source: SEC annual filings · Hover bar to view year data · Click to view original filing

Employees History

Filing Date	Period End	Employees	Change (1Y)	Growth (1Y)
2026-03-23	2025-12-31	200,000	+0	+0.00%
2025-03-14	2024-12-31	200,000	+199,998	+9999900.00%
2024-03-29	2023-12-31	2	+0	+0.00%
2023-03-31	2022-12-31	2	+0	+0.00%
2022-03-31	2021-12-31	2	+0	+0.00%
2021-04-01	2020-12-31	2	+0	+0.00%
2020-03-30	2019-12-31	2	-1	-33.33%
2019-03-15	2018-12-31	3	+0	+0.00%
2018-03-23	2017-12-31	3	—	—

▸ Source: SEC Annual Reports (Form 10-K / 20-F). Employee counts as of fiscal year end. Click the ↗ icon at the end of a row to open the original SEC filing in a new tab.

Related Companies — Employee Count

Biotechnology

#SymbolCompanyEmployeesMkt Cap

NRXP

NRx Pharmaceuticals, Inc.YOU

200,000$75M #2

IPSC

Century Therapeutics, Inc.

Werewolf Therapeutics, Inc.

Coeptis Therapeutics, Inc.

5$58M

Source: /stock-peers + /profile.fullTimeEmployees · Click row → /employees · Sorted by headcount · NRXP peer comparison

About NRXP employees

NRXP Employees · Headcount

NRx Pharmaceuticals, Inc. (NRXP) employee data is sourced from the annual SEC 10-K filing. As of 2025, NRx Pharmaceuticals, Inc. had 200,000 full-time employees globally. Full-time employees only. Global consolidated headcount.

NRx Pharmaceuticals, Inc. employs 200,000 full-time employees as of the latest filing within the Biotechnology industry. Revenue per employee stands at $6, reflecting the company's operational efficiency.

NRx Pharmaceuticals, Inc.'s workforce increased by 0 (0.00%) in 2025 compared to the prior fiscal year. The historical trend reflects the company's expansion and contraction cycles.

NRx Pharmaceuticals, Inc.'s revenue per employee of $6 positions it among the notable performers in the Biotechnology sector for operational efficiency.

Revenue Financial statements Net income SEC filings Price history Forecast & ratings Ownership Earnings

Frequently Asked Questions

NRXP Employees · 5 questions

As of the latest SEC 10-K filing (2025), NRx Pharmaceuticals, Inc. had 200,000 full-time employees globally. This figure is sourced from the company's mandatory annual disclosure to the SEC.

NRx Pharmaceuticals, Inc. employee counthow many employees does NRx Pharmaceuticals, Inc. haveNRXP total employees 2025

▸ Data source: FMP /historical-employee-count · SEC EDGAR annual filings · As reported · Global consolidated headcount · As of 2026-03-23